Alex Marson is Director of the Gladstone-UCSF Institute of Genomic Immunology, and Professor in the UCSF Department of Medicine. The Marson Lab is pioneering new CRISPR gene editing technologies that offer faster, cheaper, and more precise ways to re-write DNA programs in human immune cells. With these tools, the lab is probing the genetic underpinnings of Type 1 diabetes and other immune-mediated diseases and engineering new cellular immunotherapies.
Marson attended college and medical school at Harvard. He received a master’s degree in Biological Sciences from Cambridge University and a Ph.D. in Biology from MIT. Marson was a resident at the Brigham and Women’s Hospital and completed clinical training in Infectious Diseases at UCSF. He started his lab as a UCSF Sandler Faculty Fellow in 2013. Marson is the scientific director for Human Health at the Innovative Genomics Institute (IGI). He is Director of the Parker Institute for Cancer Immunotherapy at Gladstone and was selected as one of the inaugural Investigators of the Chan Zuckerberg Biohub San Francisco.
